Add time:07/13/2019         Source:sciencedirect.com

2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones (F2-NH-DABOs) 4, 5 belonging to the dihydro-alkoxy-benzyl-oxopyrimidine (DABO) family and bearing different alkyl- and arylamino side chains at the C2-position of the pyrimidine ring were designed as active against wild type (wt) human immunodeficiency virus type 1 (HIV-1) and some relevant HIV-1 mutants. Biological evaluation indicated the importance of the further anchor point of compounds 4, 5 into the non-nucleoside binding site (NNBS): newly synthesized compounds were highly active against both wild type and the Y181C HIV-1 strains. In anti-wt HIV-1 assay the potency of amino derivatives did not depend on the size or shape of the C2-amino side chain, but it associated with the presence of one or two methyl groups (one at the pyrimidine C5-position and the other at the benzylic carbon), being thymine, α-methyluracil or α-methylthymine derivatives almost equally active in reducing wt HIV-1-induced cytopathogenicity in MT-4 cells. Against the Y181C mutant strain, 2,6-difluorobenzyl-α-methylthymine derivatives 4d, 5h′–n′ showed the highest potency and selectivity among tested compounds, both a properly sized C2–NH side chain and the presence of two methyl groups (at C5 and benzylic positions) being crucial for high antiviral action.

We also recommend Trading Suppliers and Manufacturers of 2-methoxyethyl 2-amino-4-(3,4-difluorophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate (cas 445382-17-2). Pls Click Website Link as below: cas 445382-17-2 suppliers